The Orthopaedic Hospital Research Center, located on the UCLA Westwood campus, was constructed in 2007. The five-story, 95,000-square-foot facility is another result of the cooperative effort with UCLA. It is here that the research activities of Los Angeles Orthopaedic Hospital and UCLA combine to create the largest collaborative and coordinated orthopaedic research effort in the United States. The partnership enables LAOH to greatly expand its musculoskeletal research activities to explore and develop new technologies for the discipline of orthopaedic surgery, in addition to new developments in gene therapy, musculoskeletal oncology, tissue engineering and biomedical engineering.
With the establishment of the Orthopaedic Hospital Research Center, scientists have the ideal setting and resources to find new treatments and cures for traumatic and non-traumatic injury to the musculoskeletal system. This includes research on arthritis and arthropathies; developmental diseases such as Muscular Dystrophy, cerebral palsy and dwarfism; hip, knee, shoulder, ankle and spine replacement; musculoskeletal cancer; musculoskeletal tissue repair and regeneration; and pediatric and adult fracture syndromes, among others.
Orthopaedic Hospital Research Center (OHRC) Milestones
• July – Initiated a trans-disciplinary research program in musculoskeletal research involving the Schools of Medicine, Dentistry and Engineering as well as the UCLA College and Broad Stem Cell Institute.
• August – OHRC doors opened. 2008 • June – Increased grant funding for research fourfold to $2.0 million.
• March – Submitted first set of bone stem cell grants to the California Institute for Regenerative Medicine (CIRM). • May – John S. Adams, M.D., and Karen Lyons, Ph.D., submitted first National Institutes of Health (NIH) training grant in regenerative orthopaedic medicine.
• July – Received first set of faculty and fellowship grants from the Broad Stem Cell Institute.
• February – Received first stem cell grant from the CIRM for $5.4 million (over three years).
• June – Received five years of funding worth $2.5 million for an NIH Training Grant; with Dr. Adams as co-director, received a five-year, $90-million Clinical and Translational Science Award from the NIH; increased grant funding for research to $3.6 million annually.